ARQL News and Press, ArQule Inc. From 05/02/19

Shares of Guardant Health ( GH ) have been on quite a run since its IPO priced at $19 in October of last year. In fact, in just a few short months, the stock was a five bagger at one point in March. The leader in liquid biopsy testing was identified by multiple ROTY members as an intriguing ...

ArQule, Inc. (ARQL) Q1 2019 Earnings Conference Call May 01, 2019 09:00 AM ET Company Participants Marc Schegerin - Chief Financial Officer Paolo Pucci - Chief Executive Officer Peter Lawrence - President and Chief Operating Officer Brian Schwartz - Head of R&D Conferenc...

ArQule (NASDAQ: ARQL ): Q1 GAAP EPS of -$0.09 misses by $0.01 . More news on: ArQule, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Conference call scheduled today at 9:00 a.m. ET ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the first quarter, 2019. For the quarter ended March 31, 2019, the Company reported a net loss of $10,267,000, or $0.09 per share, compared with net loss of $6,5...

Chinese registrational clinical trial for derazantinib to begin in 2H 2019 ArQule, Inc.’s (Nasdaq: ARQL) partner, Sinovant Sciences, announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the Center for Drug Evaluation at the China National Me...

There is a tide in the affairs of men, which taken at the flood leads to fortune. Omitted all the voyage of their life, Is bound in shallows and in miseries. On such a full sea are we now afloat; And we must take the current when it serves Or lose our ventures. &#x...

ArQule , Inc. (Nasdaq: ARQL) today announced it will report financial results for the first quarter of 2019 before the market opens on Wednesday, May 1, 2019. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general b...

By Jonathan Liss Listen and subscribe to the Marketplace Roundtable on these podcast platforms: iTunes/Apple Podcasts Spotify Stitcher Jonathan Faison doesn't want prospective biotech investors to think that they need some sort of "special sauce" to succeed...

ArQule, Inc. (Nasdaq: ARQL) today announced that Peter Lawrence, President and Chief Operating Officer, and Dr. Marc Schegerin, Chief Financial Officer and Head of Strategy, will present at the 18th Annual Needham Healthcare Conference on April 9, 2019 at 10:00 a.m. ET at the Westin New York...

The following slide deck was published by ArQule, Inc. in conjunction with this Read more ...